Skip to main content
Equibles

Legal & General Group Plc

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 764068 London, X0
Back to RNAC Full portfolio

Position in RNAC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$15,369
+$9,742 QoQ
Shares Held
1,475
+61.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 95 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. RNAC ranks #261 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,870,015 $928,892,550
2 REGN
Regeneron Pharmaceuticals, Inc.
 759,971 $473,872,316
3 ALNY
Alnylam Pharmaceuticals, Inc.
 924,561 $278,320,596
4 RPRX
Royalty Pharma plc
 3,800,504 $213,094,258
5 INCY
Incyte Corp
 1,605,980 $182,053,892
6 ARGX
Argenx SE
 177,164 $164,367,443
7 INSM
INSMED Inc
 826,431 $88,114,072
8 RVMD
Revolution Medicines, Inc.
 381,366 $71,422,223

All Filings in RNAC

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,369 1,475
2026-03-31 $5,627 915
2025-12-31 $6,762 938
2025-09-30 $9,586 938
2025-06-30 $9,745 938
2025-03-31 $15,157 1,150
2024-12-31 $20,596 1,150
2024-09-30 $12,912 801
2024-06-30 $21,635 801
2024-03-31 $7,562 11,634
2023-12-31 $8,015 11,634
2023-09-30 $12,332 11,634
2023-06-30 $13,987 12,489
2022-03-31 $11,699 9,512
2021-12-31 $31,008 9,512
2021-09-30 $39,569 9,512
2021-06-30 $39,760 9,512
2021-03-31 $30,969 6,844
2020-12-31 $21,758 7,181
2020-09-30 $17,808 7,181
2020-06-30 $27,939 9,838